EGFR and hepatocellular carcinoma: GSEA analysis results suggested a potential biological molecular mechanism of risk signature in HCC progression via Wnt (Dai et al., 2019; Hu et al., 2019; Huynh et al., 2019; Jin et al., 2019; Li et al., 2019; Tan et al., 2019) and ERBB (Ni et al., 2020) signaling pathways and others.